Overview and Scope
Thrombectomy devices refer to vacuum aspiration to remove the occlusive clot in acute ischemic stroke. Surgical thrombectomy includes pulling or sucking out the clot with a specially developed clot removal device introduced through a catheter to restore blood flow.
Sizing and Forecast
The thrombectomy devices market size has grown strongly in recent years. It will grow from $1.46 billion in 2023 to $1.58 billion in 2024 at a compound annual growth rate (CAGR) of 8.4%. The growth in the historic period can be attributed to increased incidence of stroke, aging population and vascular disorders, advancements in minimally invasive procedures, awareness and early intervention, improved clinical outcomes.
The thrombectomy devices market size is expected to see strong growth in the next few years. It will grow to $2.1 billion in 2028 at a compound annual growth rate (CAGR) of 7.4%. The growth in the forecast period can be attributed to expanding aging population, advances in thrombectomy technology, global initiatives for stroke awareness, integration with telemedicine, collaborations for research and development. Major trends in the forecast period include introduction of next-generation stent retrievers, focus on neurointerventional thrombectomy, integration of imaging guidance technologies, enhancements in thrombus detection and imaging, shift toward outpatient thrombectomy procedures.
To access more details regarding this report, visit the link:
https://www.thebusinessresearchcompany.com/report/thrombectomy-devices-global-market-report
Segmentation & Regional Insights
The thrombectomy devices market covered in this report is segmented –
1) By Product Type: Aspiration Thrombectomy Devices, Mechanical Thrombectomy Devices, Ultrasonic Thrombectomy Devices, Other Product Types
2) By Application: Cardiovascular Application, Peripheral Application, Neurovascular Application
3) By End-User: Hospitals, Surgical centers, Ambulatory, Academia, Contract Research Organizations(CROs)
North America was the largest region in the thrombectomy devices market in 2023. Asia-Pacific is expected to be the fastest-growing region in the global thrombectomy devices market report during the forecast period. The regions covered in the thrombectomy devices market report are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East, Africa
Intrigued to explore the contents? Secure your hands-on sample copy of the report:
https://www.thebusinessresearchcompany.com/sample_request?id=10752&type=smp
Major Driver Impacting Market Growth
An increase in the incidence of cardiovascular diseases is expected to propel the growth of the thrombectomy devices market going forward. Cardiovascular diseases (CVDs) are a group of disorders that affect the heart and blood vessels, including coronary artery disease, heart failure, and arrhythmias. Thrombectomy is a procedure used to remove blood clots that have formed within blood vessels, including those in cardiovascular diseases such as acute ischemic stroke and acute myocardial infarction (heart attack); as a result, an increase in the incidence of cardiovascular diseases increases the demand for thrombectomy devices. For instance, in January 2023, according to a report shared by the American Heart Association, a US-based non-profit organization that supports cardiovascular medical research, 928,741 people died in the United States in 2020 as a result of cardiovascular disease (CVD), which was reported as the primary cause of death. Worldwide mortality from CVD was estimated at 19.05 million in 2020. Therefore, an increase in the incidence of cardiovascular disease devices is driving the growth of the thrombectomy devices market.
Key Industry Players
Major companies operating in the thrombectomy devices market report are Stryker Corporation, Medtronic PLC, Boston Scientific Corporation, Johnson and Johnson, Terumo Corporation, Penumbra Inc., Edwards Lifesciences Corporation, Argon Medical Devices Inc., Teleflex Incorporated, AngioDynamics, Koninklijke Philips NV, Spectranetics Corporation, Abbott Laboratories, Inari Medical Inc., C. R. Bard Inc., BTG International Ltd., Walk Vascular LLC, Phenox GmbH, Acandis GmbH & Co. KG, Straub Medical AG, MicroVention Inc., Vascular Solutions Inc., Rapid Medical, Endo International PLC, Acrostak AG, Neuravi Limited, Control Medical Technology LLC, Kaneka Corporation, Arteria Therapeutics Inc., Baxter International
The thrombectomy devices market report table of contents includes:
1. Executive Summary
2. Thrombectomy Devices Market Characteristics
3. Thrombectomy Devices Market Trends And Strategies
4. Thrombectomy Devices Market – Macro Economic Scenario
5. Global Thrombectomy Devices Market Size and Growth
.
.
.
31. Global Thrombectomy Devices Market Competitive Benchmarking
32. Global Thrombectomy Devices Market Competitive Dashboard
33. Key Mergers And Acquisitions In The Thrombectomy Devices Market
34. Thrombectomy Devices Market Future Outlook and Potential Analysis
35. Appendix
Explore the trending research reports from TBRC:
Contact Us:
The Business Research Company
Europe: +44 207 1930 708
Asia: +91 88972 63534
Americas: +1 315 623 0293
Email: [email protected]
Follow Us On:
LinkedIn: https://in.linkedin.com/company/the-business-research-company
Twitter: https://twitter.com/tbrc_info
Facebook: https://www.facebook.com/TheBusinessResearchCompany
YouTube: https://www.youtube.com/channel/UC24_fI0rV8cR5DxlCpgmyFQ
Blog: https://blog.tbrc.info/
Healthcare Blog: https://healthcareresearchreports.com/
Global Market Model: https://www.thebusinessresearchcompany.com/global-market-model
